Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Taro Pharmaceutical Indu... (TARO)

Taro Pharmaceutical Industries Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:TARO
DateTimeSourceHeadlineSymbolCompany
08/05/202414:28Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
08/05/202414:07Business WireLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma MergerNYSE:TAROTaro Pharmaceutical Industries Ltd
15/04/202413:00Business WireTaro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.NYSE:TAROTaro Pharmaceutical Industries Ltd
11/03/202410:19Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
15/02/202413:36Edgar (US Regulatory)Form SC 13E3 - Going private transaction by certain issuersNYSE:TAROTaro Pharmaceutical Industries Ltd
30/01/202418:18PR Newswire (US)Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law FirmNYSE:TAROTaro Pharmaceutical Industries Ltd
30/01/202412:00PR Newswire (US)Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for TaroNYSE:TAROTaro Pharmaceutical Industries Ltd
26/01/202414:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
25/01/202422:06Business WireTaro Provides Results for December 31, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
19/01/202421:15Business WireTaro to Release Third Quarter Results on January 25, 2024NYSE:TAROTaro Pharmaceutical Industries Ltd
17/01/202421:36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
17/01/202421:35Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
17/01/202421:30PR Newswire (US)Taro Announces Merger Agreement with Sun PharmaNYSE:TAROTaro Pharmaceutical Industries Ltd
17/01/202421:30PR Newswire (Canada)Taro Announces Merger Agreement with Sun PharmaNYSE:TAROTaro Pharmaceutical Industries Ltd
04/01/202421:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
11/12/202321:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
11/12/202321:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
17/11/202321:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
27/10/202314:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
26/10/202322:00Business WireTaro Provides Results for September 30, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
19/10/202321:30Business WireTaro to Release Second Quarter Results on October 26, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
27/07/202315:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
27/07/202301:36Business WireTaro Provides Results for the Quarter Ended June 30, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
19/07/202321:00Business WireTaro to Release First Quarter Results on July 26, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
19/07/202312:00PR Newswire (US)Krensavage Asset Management Opposes Sun's Lowball Bid for TaroNYSE:TAROTaro Pharmaceutical Industries Ltd
30/06/202314:00Business WireTaro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
29/06/202321:32Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NYSE:TAROTaro Pharmaceutical Industries Ltd
28/06/202322:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:TAROTaro Pharmaceutical Industries Ltd
28/06/202322:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
31/05/202322:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:TAROTaro Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TARO